Literature DB >> 15737414

A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein.

Pakamatz Khawplod1, Ken-Ichi Inoue, Yoko Shoji, Henry Wilde, Sukathida Ubol, Akira Nishizono, Ichiro Kurane, Kinjiro Morimoto.   

Abstract

Virus-neutralizing antibodies (VNAs) against rabies virus play a major role in protection from rabies. The rapid fluorescent focus inhibition test (RFFIT) has been internationally recognized as a standard in vitro test for measuring the VNA. CVS strain of rabies virus is used as challenge virus and the infected cells are indirectly detected by staining with fluorescein isothiocyanate (FITC)-conjugated rabies antibody which is expensive and high-quality products are often in short supply. In this study, a recombinant rabies virus strain carrying a green fluorescent protein (GFP) gene, rHEP-GFP, was used as a challenge virus in the virus neutralization assay. Expression of the GFP could be readily detected in the infected cells under a fluorescent microscope. This novel RFFIT modification RFFIT-GFP is a neutralization test, and it is based on the sound principle of the standard RFFIT using 96-well plates. VNA titers in 25 human, 18 canine and 15 horse sera have been compared between the RFFIT and RFFIT-GFP methods. The results obtained by the both methods showed good agreement between both methods in all sera investigated (coefficient of correlation, r = 0.98). It allowed direct detection of virus by expression of GFP and might be applicable for other viruses. The novel method is convenient, economical and a reliable tool not requiring expensive FITC-conjugated antibody for routine rabies VNA assays.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737414     DOI: 10.1016/j.jviromet.2004.12.003

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  10 in total

1.  Establishment and preliminary application of a rapid fluorescent focus inhibition test (RFFIT) for rabies virus.

Authors:  Pengcheng Yu; Xinjun Lv; Xinxin Shen; Qing Tang; Guodong Liang
Journal:  Virol Sin       Date:  2013-07-25       Impact factor: 4.327

Review 2.  Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.

Authors:  Michele Bouloy; Ramon Flick
Journal:  Antiviral Res       Date:  2009-08-12       Impact factor: 5.970

3.  Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay.

Authors:  Junji Sashihara; Peter D Burbelo; Barbara Savoldo; Theodore C Pierson; Jeffrey I Cohen
Journal:  Virology       Date:  2009-07-07       Impact factor: 3.616

4.  Generation of recombinant rabies Virus CVS-11 expressing eGFP applied to the rapid virus neutralization test.

Authors:  Xianghong Xue; Xuexing Zheng; Hongru Liang; Na Feng; Yongkun Zhao; Yuwei Gao; Hualei Wang; Songtao Yang; Xianzhu Xia
Journal:  Viruses       Date:  2014-04-04       Impact factor: 5.048

5.  Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles.

Authors:  Sarah Moeschler; Samira Locher; Karl-Klaus Conzelmann; Beate Krämer; Gert Zimmer
Journal:  Viruses       Date:  2016-09-16       Impact factor: 5.048

6.  Comparison of a Micro-Neutralization Test with the Rapid Fluorescent Focus Inhibition Test for Measuring Rabies Virus Neutralizing Antibodies.

Authors:  Todd G Smith; Amy T Gilbert
Journal:  Trop Med Infect Dis       Date:  2017-07-07

7.  Photocontrollable mononegaviruses.

Authors:  Maino Tahara; Yuto Takishima; Shohei Miyamoto; Yuichiro Nakatsu; Kenji Someya; Moritoshi Sato; Kenzaburo Tani; Makoto Takeda
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

8.  A high throughput neutralization test based on GFP expression by recombinant rabies virus.

Authors:  Jillybeth Burgado; Lauren Greenberg; Mike Niezgoda; Amrita Kumar; Victoria Olson; Xianfu Wu; Panayampalli Subbian Satheshkumar
Journal:  PLoS Negl Trop Dis       Date:  2018-12-14

9.  A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa.

Authors:  Edward Wright; Suzanne McNabb; Trudy Goddard; Daniel L Horton; Tiziana Lembo; Louis H Nel; Robin A Weiss; Sarah Cleaveland; Anthony R Fooks
Journal:  Vaccine       Date:  2009-11-27       Impact factor: 3.641

10.  A recombinant rabies virus carrying GFP between N and P affects viral transcription in vitro.

Authors:  Jun Luo; Jing Zhao; Qin Tian; Weiyu Mo; Yifei Wang; Hao Chen; Xiaofeng Guo
Journal:  Virus Genes       Date:  2016-03-08       Impact factor: 2.332

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.